Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
2,582
Total Claims
$223K
Drug Cost
386
Beneficiaries
$579
Cost/Patient
Risk Score Breakdown 5/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+35%
Opioid rate vs peers
3.0% vs 2.2% avg
-59%
Cost per patient vs peers
$579 vs $1,411 avg
+15%
Brand preference vs peers
12.2% vs 10.6% avg
Opioid Prescribing
3.0%
Opioid Rate
78
Opioid Claims
$1,902
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 314 claims · $161K
Generic: 2,250 claims · $61K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 28 | $29K |
| Apixaban | 18 | $17K |
| Sumatriptan Succinate | 29 | $12K |
| Umeclidinium Brm/Vilanterol Tr | 18 | $8,445 |
| Rivaroxaban | 11 | $7,478 |
| Tiotropium Bromide | 13 | $7,207 |
| Fluticasone Propion/Salmeterol | 11 | $5,922 |
| Atorvastatin Calcium | 161 | $3,177 |
| Omeprazole | 78 | $2,089 |
| Metoprolol Succinate | 60 | $1,913 |
| Albuterol Sulfate | 26 | $1,758 |
| Amlodipine Besylate | 123 | $1,524 |
| Albuterol Sulfate | 44 | $1,486 |
| Losartan Potassium | 61 | $1,467 |
| Glipizide | 39 | $1,384 |
Prescribing Profile
Patient Profile
72
Avg Age
61%
Female
1.39
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About